Back to Search
Start Over
No impact of disease duration on response to tildrakizumab treatment among patients with moderate‐to‐severe plaque psoriasis: Post hoc analyses from two phase 3 (reSURFACE 1 and reSURFACE 2) and one phase 4 (TRIBUTE) studies
- Source :
- Skin Health and Disease, Vol 3, Iss 5, Pp n/a-n/a (2023)
- Publication Year :
- 2023
- Publisher :
- Wiley, 2023.
- Subjects :
- Dermatology
RL1-803
Subjects
Details
- Language :
- English
- ISSN :
- 2690442X
- Volume :
- 3
- Issue :
- 5
- Database :
- Directory of Open Access Journals
- Journal :
- Skin Health and Disease
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.183cda1e49764584b6cbb5f02940de7e
- Document Type :
- article
- Full Text :
- https://doi.org/10.1002/ski2.263